M&A Deal Summary |
|
|---|---|
| Date | 2015-07-02 |
| Target | Pfizer - Ion Channel and Transporter Drug R&D |
| Sector | Life Science |
| Buyer(s) | XRpro Sciences |
| Sellers(s) | Pfizer |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Life Science |
| Employees | 9 |
XRpro Sciences, Inc. is a drug discovery company.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 81,000 |
| Revenue | 63.6B USD (2024) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 19 |
| Sector: Life Science M&A | 7 of 14 |
| Type: Divestiture M&A Deals | 10 of 15 |
| Country: United States M&A | 7 of 13 |
| Year: 2015 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-02-05 |
Hospira
Lake Forest, Illinois, United States Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Hospira, Inc. is based in Lake Forest, Illinois. |
Buy | $17.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-10-01 |
GlaxoSmithKline - Nimenrix and Mencevax
Brentford, United Kingdom GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. |
Buy | - |
